Connect Biopharma Holdings (CNTB) Other Non Operating Income (2024 - 2026)
Connect Biopharma Holdings (CNTB) posted Other Non Operating Income of -$3000.0 for Q1 2026, down 105.0% sequentially from $60000.0 in Q4 2025, and down 100.59% YoY from $509000.0 in Q1 2025.
Connect Biopharma Holdings (CNTB) Other Non Operating Income (2024 - 2026) Analysis & Trends
Connect Biopharma Holdings has reported Other Non Operating Income for 3 years, with the latest figure at -$3000.0 in Q1 2026.
- Quarterly Other Non Operating Income fell 100.59% year-over-year to -$3000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11000.0 (down 97.11% YoY) and the FY2025 annual result came in at $523000.0, down 79.84% from the prior year.
- Other Non Operating Income slipped to -$3000.0 in Q1 2026 per CNTB's latest filing, from $60000.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $2.7 million in Q1 2024 and troughed at -$108000.0 in Q3 2024.
- A 3-year average of $346000.0 and a median of -$3000.0 in 2026 frame the typical range for Other Non Operating Income.
- The widest YoY moves for Other Non Operating Income: up 300.0% in 2025, down 533.33% in 2025.
- Over 3 years, Other Non Operating Income stood at -$30000.0 in 2024, then jumped by 300.0% to $60000.0 in 2025, then plunged by 105.0% to -$3000.0 in 2026.
- According to Business Quant data, Other Non Operating Income over the past three periods registered -$3000.0, $60000.0, and -$7000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Connect Biopharma Holdings | 148.41 Mn | 148.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 67,000.00 |
| Mar 31, 2026 | -3,000.00 |
| Dec 31, 2025 | 60,000.00 |
| Sep 30, 2025 | -7,000.00 |
| Jun 30, 2025 | -39,000.00 |
| Mar 31, 2025 | 509,000.00 |
| Dec 31, 2024 | -30,000.00 |
| Sep 30, 2024 | -108,000.00 |
| Jun 30, 2024 | 9,000.00 |
| Mar 31, 2024 | 2.72 Mn |